We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

64 hedge funds and large institutions have $70.2M invested in OptiNose in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% less ownership

Funds ownership: 3.09%2.85% (-0.25%)

6% less funds holding

Funds holding: 6864 (-4)

21% less capital invested

Capital invested by funds: $89.2M → $70.2M (-$19M)

24% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 17

30% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 27

Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
19
Reduced
27
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
76
Legal & General Group
United Kingdom
-$14K -258 Closed
Citigroup
77
Citigroup
New York
-$7.86K -154 Closed
AIP
78
Ameritas Investment Partners
Nebraska
-$8K -139 Closed
Simplex Trading
79
Simplex Trading
Illinois
-$3.42K -67 Closed

OPTN Hedge Fund Activity: Q2 2021 in Review

64 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2021, worth a combined $70.2M — down 21% from $89.2M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of OPTN and 13 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 19 added.

The largest buyer was GMT Capital, adding an estimated $3.34M. The largest seller was BlackRock, cutting an estimated $6.27M.

  • 64 institutional investors held OptiNose (OPTN) as of Q2 2021, down from 68 in Q1 2021.
  • Funds reported $70.2M of OptiNose stock for Q2 2021, down 21% quarter-over-quarter.
  • 13 funds opened new OptiNose positions in Q2 2021 and 17 closed out, a net change of -4 holders.
  • The largest OptiNose buyer in Q2 2021 was GMT Capital, an estimated $3.34M added.
  • The largest OptiNose seller in Q2 2021 was BlackRock, an estimated $6.27M sold.

Based on aggregated 13F filings for Q2 2021.